HomeCSCI • NASDAQ
COSCIENS Biopharma Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 2.75M | 17.63% |
Operating expense | 3.33M | -27.26% |
Net income | -2.70M | -89.94% |
Net profit margin | -98.25 | -61.46% |
Earnings per share | — | — |
EBITDA | -2.07M | 38.84% |
Effective tax rate | -0.04% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.33M | -66.43% |
Total assets | 27.56M | -44.93% |
Total liabilities | 20.46M | -14.09% |
Total equity | 7.10M | — |
Shares outstanding | 3.18M | — |
Price to book | 1.41 | — |
Return on assets | -20.04% | — |
Return on capital | -54.15% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.70M | -89.94% |
Cash from operations | -4.45M | -220.16% |
Cash from investing | -48.00K | -100.19% |
Cash from financing | -107.00K | 15.08% |
Net change in cash | -4.43M | -118.21% |
Free cash flow | -3.34M | -124.57% |
Previous close
$3.17
Day range
$3.01 - $3.10
Year range
$1.96 - $4.61
Market cap
10.03M USD
Avg Volume
12.66K
P/E ratio
-
Dividend yield
-
About
Founded
1990
Headquarters
Website
Employees
40
